The Latest Breaking News from FDA

The U.S. Court of Appeals for the D.C. Circuit takes issue with how the FDA evaluated Fontem's unflavored vaping products.

With innovative approaches and cutting-edge technologies, biotech has ushered in a new era of possibilities in the medical field. Hence, investing in three fundamentally sound biotech stocks, Equillium, Inc. (EQ), Theratechnologies (THTX), and Exelixis (EXEL), could yield healthy profits. Learn more….

Abrysvo was also approved by the FDA in May 2023 to prevent RSV illness in adults 60 years and older

Texas joins a handful of states turn to the north for cheaper drugs. But feds have been slow to approve requests, three years after giving initial OK.

With the Food and Drug Administration’s Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV, for use during late pregnancy, the U.S. will soon have a major new tool at its disposal to protect infants against the highly contagious virus.

Move came after FDA said earlier that people should ‘properly discard’ the products if they have purchased it

While schoolchildren go without needed medication, government agencies shirk responsibility by blaming manufacturers.

The pharma industry is anticipated to stay buoyed in the years to come with consistent medical breakthroughs and rising need to serve an aging population. Therefore, pharma stocks Johnson & Johnson (JNJ), Novartis AG (NVS), and Dr. Reddy's Laboratories (RDY), which possess promising pipelines, could be wise portfolio additions now.…

A federal judge has ruled that West Virginia can restrict the sale of the abortion pill

A new study calls into question the sustainability and health risks of eco-friendly straws

Move came after FDA said earlier that people should ‘properly discard’ the products if they have purchased it